| SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters PJ Halfmann, S Iida, K Iwatsuki-Horimoto, T Maemura, M Kiso, ... Nature 603 (7902), 687-692, 2022 | 588 | 2022 |
| Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA. 5 Omicron variant in mice SM Scheaffer, D Lee, B Whitener, B Ying, K Wu, CY Liang, H Jani, ... Nature medicine 29 (1), 247-257, 2023 | 171 | 2023 |
| Defining the risk of SARS-CoV-2 variants on immune protection MM DeGrace, E Ghedin, MB Frieman, F Krammer, A Grifoni, A Alisoltani, ... Nature 605 (7911), 640-652, 2022 | 160 | 2022 |
| Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains JB Case, S Mackin, JM Errico, Z Chong, EA Madden, B Whitener, ... Nature communications 13 (1), 3824, 2022 | 144 | 2022 |
| The SARS-CoV-2 B. 1.1. 529 Omicron virus causes attenuated infection and disease in mice and hamsters M Diamond, P Halfmann, T Maemura, K Iwatsuki-Horimoto, S Iida, M Kiso, ... Research square, rs. 3. rs-1211792, 2021 | 128 | 2021 |
| Neutralization, effector function and immune imprinting of Omicron variants A Addetia, L Piccoli, JB Case, YJ Park, M Beltramello, B Guarino, H Dang, ... Nature 621 (7979), 592-601, 2023 | 107 | 2023 |
| A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope LA VanBlargan, LJ Adams, Z Liu, RE Chen, P Gilchuk, S Raju, BK Smith, ... Immunity 54 (10), 2399-2416. e6, 2021 | 101 | 2021 |
| Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2 SR Mackin, P Desai, BM Whitener, CE Karl, M Liu, RS Baric, DK Edwards, ... Nature microbiology 8 (4), 569-580, 2023 | 84 | 2023 |
| Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice B Ying, SM Scheaffer, B Whitener, CY Liang, O Dmytrenko, S Mackin, ... Cell 185 (9), 1572-1587. e11, 2022 | 81 | 2022 |
| Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains B Ying, B Whitener, LA VanBlargan, AO Hassan, S Shrihari, CY Liang, ... Science translational medicine 14 (630), eabm3302, 2021 | 77 | 2021 |
| Consortium Mount Sinai Pathogen Surveillance (PSP) study group PJ Halfmann, S Iida, K Iwatsuki-Horimoto, T Maemura, M Kiso, ... Douek DC, Sullivan NJ, Thackray LB, Ueki H, Yamayoshi S, Imai M, Perlman S …, 2022 | 42 | 2022 |
| Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B. 1.1. 529 infection in mice B Ying, SM Scheaffer, B Whitener, CY Liang, O Dmytrenko, S Mackin, ... BioRxiv, 2022 | 38 | 2022 |
| Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants A Addetia, L Piccoli, JB Case, YJ Park, M Beltramello, B Guarino, H Dang, ... Biorxiv, 2023.01. 17.523798, 2023 | 31 | 2023 |
| prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis KA Dowd, D Sirohi, SD Speer, LA VanBlargan, RE Chen, S Mukherjee, ... Proceedings of the National Academy of Sciences 120 (3), e2218899120, 2023 | 18 | 2023 |
| Vertebrate-class-specific binding modes of the alphavirus receptor MXRA8 O Zimmerman, MI Zimmerman, S Raju, CA Nelson, JM Errico, EA Madden, ... Cell 186 (22), 4818-4833. e25, 2023 | 15 | 2023 |
| Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2 GBE Stewart-Jones, SM Elbashir, K Wu, D Lee, I Renzi, B Ying, M Koch, ... Science translational medicine 15 (713), eadf4100, 2023 | 13 | 2023 |
| mRNA-1273 and Ad26. COV2. S vaccines protect against the B. 1.621 variant of SARS-CoV-2 TL Darling, B Ying, B Whitener, LA VanBlargan, TL Bricker, CY Liang, ... Med 3 (5), 309-324. e6, 2022 | 11 | 2022 |
| Computationally restoring the potency of a clinical antibody against Omicron TA Desautels, KT Arrildt, AT Zemla, EY Lau, F Zhu, D Ricci, S Cronin, ... Nature 629 (8013), 878-885, 2024 | 10 | 2024 |
| Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2 SR Mackin, P Desai, BM Whitener, CE Karl, M Liu, RS Baric, DK Edwards, ... bioRxiv, 2022 | 9 | 2022 |
| A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection LJ Adams, LA VanBlargan, Z Liu, P Gilchuk, H Zhao, RE Chen, S Raju, ... Cell Reports Medicine 4 (12), 2023 | 6 | 2023 |